AMN · NYSE · Medical - Care Facilities

AMN (AMN)

Supplies healthcare staffing, managed services, language access, and workforce technology to U.S. providers.

$34.40
vs last close−0.14 (−0.41%)
Loading prices…

AMN Healthcare Services, Inc.AMN
Health Care

Combines nurse and allied staffing, physician and leadership solutions, and workforce technology for U.S. healthcare organizations. Revenue remains tied most heavily to nurse and allied demand, while language services, vendor management, and managed-service programs broaden the platform.

Runs a healthcare workforce platform centered on Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. Services include travel nurse and allied staffing, locum tenens, interim leadership, executive search, managed-service programs, vendor management systems, language services, workforce optimization, and talent planning.

Works mainly for U.S. healthcare organizations, from hospitals and health systems to other care settings. The model combines clinician and interpreter networks with staffing operations, managed-services processes, and software that helps clients source, schedule, and manage labor.

Depends on healthcare staffing cycles, especially travel nurse demand and bill rates, with one large health-system customer contributing a material share of revenue. Labor-disruption projects can lift volumes unevenly, while vendor-management activity moves with broader staffing utilization.

Company facts

CEOCaroline S. Grace
ListedNov 13, 2001
ExchangeNYSE
HeadquartersDallas, TX
CountryUnited States
Employees2,664
CIK0001142750
ISINUS0017441017

Market cap$1.34B
EPS (ttm)$2.68
P/E (ttm)12.89
ROE15.3%
P/B1.81
P/S0.3901
Dividend yieldDiv yield
Beta0.88vs XLV 0.47

Price target$38.00+10.0%Average of 17 analysts
ConsensusBuy10 of 17 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 11, 2026BMO CapitalReiterate
Rating: Target: $26
Rating: OutperformTarget: $40
Aug 7, 2026Robert W. BairdTarget
Target: $26
Target: $36
Jul 22, 2026Truist FinancialTarget
Target: $26
Target: $40
May 13, 2026UBSReiterate
Rating: Target: $19.50
Rating: NeutralTarget: $32
May 11, 2026BMO CapitalReiterate
Rating: Target: $22
Rating: OutperformTarget: $26

Next report
Nov 5, 26
in 43 days
EPS estimate
$0.22
Revenue estimate
$648.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.75$0.45$0.30$0.39$0.22$2.10$0.77Pending
Estimate$0.52$0.19$0.17$0.19$0.22$1.60$0.19$0.22
Surprise+44.2%+136.8%+76.5%+105.3%0.0%+31.3%+307.8%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$734.7M$689.5M$658.2M$634.5M$748.2M$1.38B$673.2MPending
Estimate$694.4M$670.1M$639.6M$723.1M$723.7M$1.23B$628.4M$648.9M
Surprise+5.8%+2.9%+2.9%−12.3%+3.4%+11.7%+7.1%
Estimate$0.22
ReportedDue Nov 5, 2026
Estimate$648.9M
ReportedDue Nov 5, 2026
View details

Debt to equity104.70%
Current ratio112.80%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$687.5M$734.7M$689.5M$658.2M$634.5M$748.2M$1.38B$673.2M
Net income$7.0M−$187.5M−$1.1M−$116.2M$29.3M−$7.7M$62.2M$21.2M
Net margin1.0%0.0%0.0%0.0%4.6%0.0%4.5%3.1%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$22.3M−$202.6M$12.5M−$123.7M$8.4M$8.2M$117.2M$26.9M
YoY growth−74.4%Turned loss−68.7%Turned loss−62.1%Turned profit+836.8%Turned profit

Balance sheet, Jun 30, 2026Cash & short-term investments $361.8M · Total debt $775.8M · Total assets $2.36B · Shareholders' equity $741.3M

Revenue
$673.2M
Operating income
$26.9M
Net income
$21.2M
View details

No dividends on record.

Institutions121.12%46.98M shares
295 holders · as of Jun 30, 2026
Insiders1.00%389.1K shares
10 holders · as of Sep 16, 2026
Adds to122.12%

38.79M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 122.12%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
17.13%6.64Mas of Jun 30, 2026
Morgan StanleyInstitution
5.89%2.28Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.43%1.72Mas of Jun 30, 2026
State Street CorpInstitution
4.37%1.69Mas of Jun 30, 2026
Boston PartnersInstitution
4.32%1.67Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jun 15, 2026Mark G. Folettadirector−3,681$31.07
View details

  • HCA Healthcare

    HealthTrust arm overlaps in MSP, per diem, travel, and locums

  • RCM Technologies

    Specialty healthcare staffing in nursing, allied, and locums

  • HealthStream

    Healthcare workforce SaaS for scheduling and credentialing

  • Korn Ferry

    Executive search, interim talent, RPO, and healthcare recruiting

  • Doximity

    Physician network used for locum and permanent recruiting

Compare

CompanyPriceChange
AMN$34.40−0.41%$1.34B12.941.00.4+2.3%
HCA Healthcare$437.64−0.11%$94.85B14.714.31.2+8.7%
RCM Technologies$40.63−0.42%$289.2M18.213.20.9+20.0%
HealthStream$28.84−0.58%$847.5M40.639.52.6+12.6%
Korn Ferry$74.99−1.15%$3.86B14.312.91.3+5.7%
Doximity$26.90+1.47%$4.96B31.219.27.6+7.3%
Median18.214.31.3+8.7%